Bucillamine


Concise Prescribing Info
Indications/Uses
Rheumatoid arthritis.
Dosage/Direction for Use
Adult: PO Initial: 100 mg/day.
Adverse Reactions
Skin and kidney disorders; pemiphigus lesions.
ATC Classification
M01CC02 - bucillamine ; Belongs to the class of penicillamine and similar antirheumatic agents.
Disclaimer: This information is independently developed by CIMS based on bucillamine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in